World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
14582
World Ranking
2936
National Ranking
1379

Philip J. Norris publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Philip J. Norris sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Philip J. Norris D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Philip J. Norris sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Philip J. Norris is affiliated with the University of California, San Francisco in the United States. Their research primarily falls within the field of Medicine, with notable subfields including Infectious Diseases, Hematology, Genetics, Molecular Biology, and Virology. This range reflects a multidisciplinary approach to medical science.

The scientist's research covers several main topics, notably:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Erythrocyte Function and Pathophysiology
  • Hemoglobinopathies and Related Disorders
  • Extracellular vesicles in disease
  • Blood transfusion and management

Among recent scientific papers authored or co-authored by Philip J. Norris are the following:

  • "Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19," 2021, published in Science Translational Medicine
  • "Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray," 2021, published in Nature Communications
  • "SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay," 2021, published in Science Advances
  • "ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens," 2020, published in Cell Reports Medicine
  • "Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma," 2021, published in Journal of Clinical Immunology

Philip J. Norris frequently collaborates with several co-authors, including:

  • Mars Stone
  • Michael P. Busch
  • Clara Di Germanio
  • Steven Kleinman
  • Travis Nemkov

The scientist's work is often published in specific venues, demonstrating consistent engagement with certain academic outlets. Frequent publication venues include:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • The Journal of Infectious Diseases
  • Anesthesiology

Best Publications

  • Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

    Andrea R. Stacey;Philip J. Norris;Philip J. Norris;Li Qin;Li Qin;Elizabeth A. Haygreen

  • Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

    Sandra Lopez-Vergès;Jeffrey M. Milush;Brian S. Schwartz;Marcelo J. Pando

  • CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

    Sandra Lopez-Vergès;Jeffrey M. Milush;Suchitra Pandey;Vanessa A. York

  • Transfusion-related acute lung injury: Incidence and risk factors

    Pearl Toy;Ognjen Gajic;Peter Bacchetti;Mark R. Looney

  • The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

    Darrell J. Triulzi;Steven Kleinman;Ram M. Kakaiya;Michael. P. Busch

  • Virus and Antibody Dynamics in Acute West Nile Virus Infection

    Michael P. Busch;Steven H. Kleinman;Steven H. Kleinman;Leslie H. Tobler;Hany T. Kamel

  • IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection

    Hilario J. Ramos;Marion C. Lanteri;Gabriele Blahnik;Amina Negash

  • Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro

    Ali Danesh;Heather C. Inglis;Rachael P. Jackman;Shiquan Wu

  • Tregs control the development of symptomatic West Nile virus infection in humans and mice

    Marion C. Lanteri;Katie M. O’Brien;Whitney E. Purtha;Mark J. Cameron

  • Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

    Hiroyu Hatano;Eric L. Delwart;Eric L. Delwart;Philip J. Norris;Philip J. Norris;Tzong-Hae Lee

  • Mechanisms of red blood cell transfusion-related immunomodulation.

    Kenneth E. Remy;Mark W. Hall;Jill Cholette;Nicole P. Juffermans

  • Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.

    Monique G. P. van der Wijst;Sara E. Vazquez;George C. Hartoularos;Paul Bastard

  • Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides

    Daniel E. Kaufmann;Paul M. Bailey;John Sidney;Bradford Wagner

  • Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

    Norman L. Letvin;Srinivas S. Rao;David C. Montefiori;Michael S. Seaman

  • Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

    Alba Grifoni;John Pham;John Sidney;Patrick H O'Rourke

  • Multisite comparison of high-sensitivity multiplex cytokine assays

    Elizabeth Crabb Breen;Sandra M. Reynolds;Christopher Cox;Lisa P. Jacobson

  • A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers

    Peter W. Hunt;Alan L. Landay;Elizabeth Sinclair;Jeffrey A. Martinson

  • Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.

    Rafael R. de Assis;Aarti Jain;Rie Nakajima;Algis Jasinskas

  • HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.

    Rachel E Owen;John W Heitman;Dale F Hirschkorn;Marion C Lanteri

  • The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.

    Sheila M. Keating;Sheila M. Keating;Elizabeth T. Golub;Marek Nowicki;Mary Young

  • Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray

    Rafael R de Assis;Aarti Jain;Rie Nakajima;Algis Jasinskas

Frequent Co-Authors

Michael P. Busch
Michael P. Busch University of California, San Francisco
Sheila M. Keating
Sheila M. Keating University of California, San Francisco
Lishomwa C. Ndhlovu
Lishomwa C. Ndhlovu Cornell University
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Marcus O. Muench
Marcus O. Muench University of California, San Francisco
Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Tzong-Hae Lee
Tzong-Hae Lee Blood Systems Research Institute
Jason P. Acker
Jason P. Acker University of Alberta
Mary Young
Mary Young Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, expanding your expertise through online nursing programs can open diverse career opportunities. Many professionals consider programs like the acute care nurse practitioner certification to specialize in acute and critical care settings, complementing immunology knowledge with patient-focused clinical skills.

If you are looking to fast-track your nursing education, enrolling in an accelerated NP program provides an efficient pathway to becoming a nurse practitioner. These programs are designed for individuals with prior healthcare backgrounds aiming to advance quickly.

For those starting fresh, online RN programs for non nurses offer accessible options to enter the nursing field. This route is ideal for immunology students seeking foundational nursing skills alongside their scientific training.

Additionally, some students prefer the easiest accelerated nursing programs to gain a Bachelor of Science in Nursing quickly and with fewer barriers, paving the way for advanced practice or specialized immunology-related roles in healthcare.

Best Scientists Citing Philip J. Norris

Trending Scientists

Recently Published Articles